National HealthCare Corporation
AMEX:NHCMedical - Care Facilities
+$1.33 today
- Market cap
- $3.16B
- Beta
- 0.67
- P/E (TTM)
- 24.2
- EPS (TTM)
- $7.96
- Dividend yield
- 1.33%
Volume 0.10M
Average 0.12M
NHC Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
National HealthCare CorporationAMEX: NHC
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization growth accelerates
Q3 FY2026 depreciation & amortization of $14.58M rose 30.6% year over year, ahead of the +10.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 30.5% from the prior quarter. Over 3 fiscal years it compounded at +3.5% a year.
Context
- Depreciation & amortization amounted to 3.0% of revenue in FY2025, down 0.3 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +30.6% holds above the trailing-twelve-month pace of +10.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 44.92M USD
- Year-over-year change
- +7.0%
- 4-year CAGR
- +2.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 44.92M | +7.0% |
| FY2024 | 2024-12-31 | 41.99M | -0.1% |
| FY2023 | 2023-12-31 | 42.03M | +3.8% |
| FY2022 | 2022-12-31 | 40.49M | -0.4% |
| FY2021 | 2021-12-31 | 40.67M | — |
Depreciation & Amortization vs competitors
How NHC compares with its peers on the latest reported figures
- NHC's LTM Sep 2026 depreciation & amortization of $49.13M is the 6th highest of the 10 companies compared; the peer median is $63.04M.
- Its year-over-year change of +10.2% is the 5th highest of 10, against a peer median of +9.8%.
- Depreciation & amortization amounts to 3.1% of revenue for NHC, versus a peer median of 2.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $346.5M | +9.8% | +10.4% | 5.6% | |
| LTM Sep 2026 | $309.19M | -19.9% | +1.5% | 10.5% | |
| LTM Jun 2026 | $114.56M | +21.9% | +18.7% | 2.1% | |
| LTM Jun 2026 | $66.42M | +4.1% | +3.1% | 2.6% | |
| LTM Mar 2026 | $63.04M | +31.9% | +13.9% | 15.3% | |
| LTM Sep 2026 | $49.13M | +10.2% | +3.5% | 3.1% | |
| LTM Oct 2026 | $25.54M | -9.6% | -10.1% | 1.0% | |
| LTM Mar 2026 | $20.17M | -5.9% | +11.9% | 2.1% | |
| LTM Jun 2026 | $16.71M | +15.1% | +5.3% | 1.1% | |
| LTM Mar 2026 | $9.26M | +38.7% | +20.3% | 0.9% | |
| Peer median (excluding NHC) | $63.04M | +9.8% | +10.4% | 2.1% | |
Competitors are the stored peer set for NHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.01B | 1.07B | 1.14B | 1.3B | 1.52B |
| Cost of Revenue | 666.06M | 686.17M | 712.34M | 810.93M | 921.08M |
| Gross Profit | 344.88M | 388.11M | 429.2M | 487.01M | 596.7M |
| Gross Margin | 34.1% | 36.1% | 37.6% | 37.5% | 39.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 40.82M | 40.98M | 41.53M | 43.18M | 46.23M |
| Operating Expenses | 293.95M | 356.22M | 372.07M | 401.25M | 468.35M |
| Depreciation & Amortization | 40.67M | 40.49M | 42.03M | 41.99M | 44.92M |
| EBITDA | 191.56M | 68.28M | 131.1M | 182.53M | 213.72M |
| EBITDA Margin | 18.9% | 6.4% | 11.5% | 14.1% | 14.1% |
| Operating Income | 50.93M | 31.9M | 57.13M | 85.76M | 128.35M |
| Operating Margin | 5.0% | 3.0% | 5.0% | 6.6% | 8.5% |
| Interest Income | 4.67M | 5.13M | 8.38M | 10.1M | 9.84M |
| Interest Expense | 845K | 563K | 324K | 4.14M | 6.37M |
| Other Income / Expenses | 99.11M | (4.67M) | 31.6M | 50.65M | 34.08M |
| Income Before Tax | 150.04M | 27.23M | 88.74M | 136.41M | 162.43M |
| Pre-Tax Margin | 14.8% | 2.5% | 7.8% | 10.5% | 10.7% |
| Income Tax Expense | 10.95M | 7.25M | 23.45M | 34.32M | 39.83M |
| Net Income | 138.59M | 22.45M | 66.8M | 101.93M | 120.02M |
| Net Margin | 13.7% | 2.1% | 5.9% | 7.9% | 7.9% |
| EPS (Basic) | 9.03 | 1.46 | 4.36 | 6.62 | 7.76 |
| EPS (Diluted) | 8.99 | 1.45 | 4.34 | 6.53 | 7.67 |
| Weighted Avg Shares | 15.35M | 15.41M | 15.31M | 15.39M | 15.47M |
| Weighted Avg Shares (Diluted) | 15.42M | 15.45M | 15.38M | 15.6M | 15.65M |
National HealthCare Corporation
AMEX:NHC
Intrinsic Alpha fair value
Locked
Current Price
$201.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.